| 8173646 |
FAB I inhibitors |
William Henry Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Dalia R. Jakas |
2012-05-08 |
| 7790716 |
Fab I inhibitors |
William Henry Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Dalia R. Jakas |
2010-09-07 |
| 7557125 |
Fab I inhibitors |
William Henry Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Dalia R. Jakas |
2009-07-07 |
| 7524843 |
Fab I inhibitors |
William Henry Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Dalia R. Jakas |
2009-04-28 |
| 7056697 |
FabK variant |
David John Payne, Nicola Gail Wallis, Joshua West |
2006-06-06 |
| 7048926 |
Methods of agonizing and antagonizing FabK |
Martin Brandt, Paul M. Keller, Arunbhai H. Patel, David John Payne, Shannon Reed +4 more |
2006-05-23 |
| 7033795 |
FabK variant |
David John Payne, Nicola Gail Wallis, Joshua West |
2006-04-25 |
| 6951729 |
High throughput screening method for biological agents affecting fatty acid biosynthesis |
Howard Kallender, John Timothy Lonsdale |
2005-10-04 |
| 6846819 |
Fab I inhibitors |
William Henry Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Dalia R. Jakas |
2005-01-25 |
| 6821746 |
Methods of screening for FabK antagonists and agonists |
David John Payne, Nicola Gail Wallis, Joshua West |
2004-11-23 |